Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation

American Journal of Kidney Diseases

Volumn 45, Issue 1, 2005, Pages 102-111

  Leung, Nelson ^a   Slezak, Jeff M ^a   Bergstralh, Erik J ^a   Dispenzieri, Angela ^b   Lacy, Martha Q ^b   Wolf, Robert C ^a   Gertz, Morie A ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

Author keywords

melphalan; nephrotic syndrome; peripheral blood stem cell transplant (PBSCT); Primary amyloidosis; renal insufficiency; urine sediment

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN; CALCINEURIN INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MELPHALAN; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPOALBUMINEMIA; HYPOTENSION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PROTEINURIA; RISK FACTOR; STEM CELL TRANSPLANTATION; SURVIVAL TIME; TREATMENT OUTCOME; URINE SEDIMENT;

ADULT; AGED; AMYLOIDOSIS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MELPHALAN; MIDDLE AGED; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

EID: 11144340304     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.09.015     Document Type: Article

References (64)

1. R.A. Kyle, M.A. Gertz Primary systemic amyloidosis Clinical and laboratory features in 474 cases Semin Hematol 32 1995 45 59
2. M.A. Gertz, R.A. Kyle Amyloidosis prognosis and treatment Semin Arthritis Rheum 24 1994 124 138
3. D.J. Goldsmith, D. Sandooran, C.D. Short, N.P. Mallick, R.W. Johnson Twenty-one years survival with systemic AL-amyloidosis Am J Kidney Dis 28 1996 278 282
4. R.A. Kyle, M.A. Gertz, P.R. Greipp Long-term survival (10 years or more) in 30 patients with primary amyloidosis Blood 93 1999 1062 1066
5. M. Skinner, J. Anderson, R. Simms Treatment of 100 patients with primary amyloidosis A randomized trial of melphalan, prednisone, and colchicine versus colchicine only Am J Med 100 1996 290 298
6. M.A. Gertz, M.Q. Lacy, J.A. Lust Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis Med Oncol 16 1999 104 109
7. R.A. Kyle, M.A. Gertz, P.R. Greipp A trial of three regimens for primary amyloidosis Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine N Engl J Med 336 1997 1202 1207
8. M.A. Gertz, M.Q. Lacy, J.A. Lust Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis J Clin Oncol 17 1999 262 267
9. V. Sanchorawala, D.G. Wright, D.C. Seldin An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis Bone Marrow Transplant 28 2001 637 642
10. L.M. Dember, V. Sanchorawala, D.C. Seldin Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on AL amyloidosis-associated renal disease Ann Intern Med 134 2001 746 753
11. M.A. Gertz, M.Q. Lacy, A. Dispenzieri Stem cell transplantation for the management of primary systemic amyloidosis Am J Med 113 2002 549 555
12. G. Reich, T. Held, W. Siegert Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation Bone Marrow Transplant 27 2001 341 343
13. P. Moreau, V. Leblond, P. Bourquelot Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis A report on 21 patients Br J Haematol 101 1998 766 769
14. M.A. Gertz, M.Q. Lacy, D.A. Gastineau Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL) Bone Marrow Transplant 26 2000 963 969
15. R.L. Comenzo, M.A. Gertz Autologous stem cell transplantation for primary systemic amyloidosis Blood 99 2002 4276 4282
16. R.L. Comenzo, E. Vosburgh, R.H. Falk Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis Survival and responses in 25 patients Blood 91 1998 3662 3670
17. N. Saba, D. Sutton, H. Ross High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant Bone Marrow Transplant 24 1999 853 855
18. F.G. Brivet, D.J. Kleinknecht, P. Loirat, P.J. Landais French Study Group on Acute Renal Failure Acute renal failure in intensive care units--Causes, outcome, and prognostic factors of hospital mortality; A prospective, multicenter study Crit Care Med 24 1996 192 198
19. G.M. Chertow, J.M. Lazarus, C.L. Christiansen Preoperative renal risk stratification Circulation 95 1997 878 884
20. G. Clermont, C.G. Acker, D.C. Angus Renal failure in the ICU Comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes Kidney Int 62 2002 986 996
21. A.B. Groeneveld, D.D. Tran, J. van der Meulen, J.J. Nauta, L.G. Thijs Acute renal failure in the medical intensive care unit Predisposing, complicating factors and outcome Nephron 59 1991 602 610
22. D.M. Smith, D.D. Weisenburger, P. Bierman Acute renal failure associated with autologous bone marrow transplantation Bone Marrow Transplant 2 1987 195 201
23. R.A. Zager, J. O'Quigley, B.K. Zager Acute renal failure following bone marrow transplantation A retrospective study of 272 patients Am J Kidney Dis 13 1989 210 216
24. D.M. Wilson, J.H. Bergert, T.S. Larson, R.R. Liedtke GFR determined by nonradiolabeled iothalamate using capillary electrophoresis Am J Kidney Dis 30 1997 646 652
25. D.W. Cockcroft, M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
26. B. Pulla, Y.M. Barri, E. Anaissie Acute renal failure following bone marrow transplantation Ren Fail 20 1998 421 435
27. N. Raja, W.E. Miller, R. McMillan, J.R. Mason Ciprofloxacin-associated acute renal failure in patients undergoing high-dose chemotherapy and autologous stem cell rescue Bone Marrow Transplant 21 1998 1283 1284
28. E.P. Cohen, C.A. Lawton, J.E. Moulder, C.G. Becker, R.C. Ash Clinical course of late-onset bone marrow transplant nephropathy Nephron 64 1993 626 635
29. M.S. Akasheh, C.P. Chang, D.H. Vesole Acute tumour lysis syndrome A case in AL amyloidosis Br J Haematol 107 1999 387
30. G. Vivino, M. Antonelli, M.L. Moro Risk factors for acute renal failure in trauma patients Int Care Med 24 1998 808 814
31. I. Letourneau, M. Dorval, R. Belanger Acute renal failure in bone marrow transplant patients admitted to the intensive care unit Nephron 90 2002 408 412
32. A. de Mendonca, J.L. Vincent, P.M. Suter Acute renal failure in the ICU Risk factors and outcome evaluated by the SOFA score Int Care Med 26 2000 915 921
33. H.H. Rasmussen, L.S. Ibels Acute renal failure. Multivariate analysis of causes and risk factors Am J Med 73 1982 211 218
34. F. Jochimsen, J.H. Schafer, A. Maurer, A. Distler Impairment of renal function in medical intensive care Predictability of acute renal failure Crit Care Med 18 1990 480 485
35. E. Gruss, C. Bernis, J.F. Tomas Acute renal failure in patients following bone marrow transplantation Prevalence, risk factors and outcome Am J Nephrol 15 1995 473 479
36. C.R. Parikh, P.A. McSweeney, D. Korular Renal dysfunction in allogeneic hematopoietic cell transplantation Kidney Int 62 2002 566 573
37. A.K. Mandal, A.H. Sklar, J.B. Hudson Transmission electron microscopy of urinary sediment in human acute renal failure Kidney Int 28 1985 58 63
38. M. Graber, B. Lane, R. Lamia, E. Pastoriza-Munoz Bubble cells Renal tubular cells in the urinary sediment with characteristics of viability J Am Soc Nephrol 1 1991 999 1004
39. M. Segasothy, D.F. Birch, K.F. Fairley, P. Kincaid-Smith Urine cytologic profile in renal allograft recipients determined by monoclonal antibodies. Diagnosis of allograft rejection Transplantation 47 1989 482 487
40. H.J. Safi, S.A. Harlin, C.C. Miller Predictive factors for acute renal failure in thoracic and thoracoabdominal aortic aneurysm surgery [erratum appears in J Vasc Surg 25:93, 1997 Note: Tabor M corrected to Mohasci TG] J Vasc Surg 24 1996 338 344
41. W.S. Suen, C.K. Mok, S.W. Chiu Risk factors for development of acute renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery Angiology 49 1998 789 800
42. R.A. Lafayette, G. Pare, C.H. Schmid Pretransplant renal dysfunction predicts poorer outcome in liver transplantation Clin Nephrol 48 1997 159 164
43. M.R. Cooper, A. Fefer, J. Thompson Interferon alfa-2b/melphalan/ prednisone in previously untreated patients with multiple myeloma A phase I-II trial Invest New Drugs 5 suppl 1987 S41 S46
44. S.J. Gordon, A.D. Pearson, M.M. Reid, A.W. Craft Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma [comment] Eur J Cancer 28A 1992 1319 1323
45. W.P. Steward, J.H. Scarffe, L.Y. Dirix Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer Br J Cancer 61 1990 749 754
46. J.H. Zwaveling, H.J. Hoekstra, J.K. Maring Renal function in cancer patients treated with hyperthermic isolated limb perfusion with recombinant tumor necrosis factor-alpha and melphalan Nephron 76 1997 146 152
47. S.M. Devine, R. Sanborn, E. Jessop Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant Bone Marrow Transplant 28 2001 557 562
48. L.J. Johnston, K.E. Stockerl-Goldstein, W.W. Hu Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma Biol Blood Marrow Transplant 6 2000 555 562
49. D. Thatcher, M. Lind, G. Morgenstern High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma Cancer 63 1989 1296 1302
50. M. Kashimura, M. Kondo, T. Abe, M. Shinohara, S. Baba A case report of acute renal failure induced by melphalan in a patient with ovarian cancer Gan No Rinsho (Japanese) 34 1988 2015 2018
51. S. Tauro, F.J. Clark, N. Duncan Recovery of renal function after autologous stem cell transplantation in myeloma patients with end-stage renal failure Bone Marrow Transplant 30 2002 471 473
52. D.C. Harris, L.S. Ibels, R.B. Ravich, J.P. Isbister, J.V. Wells Multiple myeloma with renal failure. A case for intensive treatment Aust N Z J Med 13 1983 163 167
53. M. Pecherstorfer, I. Zimmer-Roth, S. Weidinger High-dose intravenous melphalan in a patient with multiple myeloma and oliguric renal failure Clin Invest 72 1994 522 525
54. P. Tosi, E. Zamagni, S. Ronconi Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure Leukemia 14 2000 1310 1313
55. G. Tricot, D.S. Alberts, C. Johnson Safety of autotransplants with high-dose melphalan in renal failure A pharmacokinetic and toxicity study Clin Cancer Res 2 1996 947 952
56. V. Sakhuja, V. Jha, S. Varma Renal involvement in multiple myeloma A 10-year study Ren Fail 22 2000 465 477
57. S. Rota, B. Mougenot, B. Baudouin Multiple myeloma and severe renal failure A clinicopathologic study of outcome and prognosis in 34 patients Medicine (Baltimore) 66 1987 126 137
58. C.G. Winearls Acute myeloma kidney Kidney Int 48 1995 1347 1361
59. F.C. Fervenza, P.M. Fitzpatrick, J. Mertz Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies Nephrol Dial Transplant 19 2004 1288 1292
60. M. Haas, S.M. Meehan, T.G. Karrison, B.H. Spargo Changing etiologies of unexplained adult nephrotic syndrome A comparison of renal biopsy findings from 1976-1979 and 1995-1997 Am J Kidney Dis 30 1997 621 631
61. D. Ganeval, B. Lacour, N. Chopin, J.P. Grunfeld Proteinuria in multiple myeloma and related diseases Am J Nephrol 10 suppl 1 1990 58 62
62. A. Fadia, L.F. Casserly, V. Sanchorawala Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis Kidney Int 63 2003 1868 1873
63. D.R. Booth, J.D. Gillmore, S.E. Booth, M.B. Pepys, P.N. Hawkins Pyrin/marenostrin mutations in familial Mediterranean fever QJM 91 1998 603 606
64. F. Mal, A. Meyrier, P. Callard The diagnostic yield of transjugular renal biopsy. Experience in 200 cases Kidney Int 41 1992 445 449